Insurer tie-ups are nothing new. But there’s been a shopping spree lately as uncertainty about the ACA recedes, providers bulk up, and government payers become more important.
The law has withstood legal challenges. More Americans have health insurance. But are more subsidies and new “copper” plans needed to make it work over the long haul?
Narrow networks mean lower premiums. Now, state insurance commissioners are wrestling with how they should be regulated so that insurers stay solvent and consumers are protected.
The NIH would get a $9 billion shot in the arm, but some fear the FDA provisions will mean lax oversight of drugs and devices.
Brace yourself for astronomically priced injections. One on track for U.S. approval looks to treat a rare form of retinal disease.